insights_auto
Parashikimi: 73.5% optimist·5.9% pesimist
Shko tek analizachevron_right
AMGN34:BVMF
Amgen Inc. BDR
91,44 BRL
arrow_upward
+0,40%(+0,36) 1D
9 nën, 4:56:00 m.d., GMT-3 · BRL
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për AMGN34...
Hap
90,54 BRL
I lartë
91,44 BRL
I ulët
90,54 BRL
Kapitalizimi i tregut
251,63 mld
Vëllimi mesatar
310,00
Vëllimi
13,00
Maksimumi 52-javor
94,72 BRL
Minimumi 52-javor
47,76 BRL
Aksionet në qarkullim
540,91 mln
Numri i punonjësve
32 mijë
Hap
90,54 BRL
I lartë
91,44 BRL
I ulët
90,54 BRL
Kapitalizimi i tregut
251,63 mld
Vëllimi mesatar
310,00
Vëllimi
13,00
Maksimumi 52-javor
94,72 BRL
Minimumi 52-javor
47,76 BRL
Aksionet në qarkullim
540,91 mln
Numri i punonjësve
32 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
Yahoo Finance UK
·
7 orë më parë
Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock
24/7 Wall St.
·
1 ditë më parë
Amgen’s Dividend Has Grown 800% Since 2011. Here’s What It Pays Today
Amgen
·
5 ditë më parë
AMGEN REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
CNBC
·
1 muaj më parë
Stocks making the biggest moves midday: Lennar, Capri, Vicor, Amgen & more
Profili
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
Rreth Amgen Inc. BDR
Drejtori ekzekutivRobert A. Bradway
Punonjësit31,5 mijë
Themeluar më1980
SeliaThousand Oaks, Kalifornia, Shtetet e Bashkuara të Amerikës
SektoriHealth Care
Industria-
Uebsajtiamgen.com